Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: Insights from the randomised GLOBAL LEADERS trial

Patrick W. Serruys*, Mariusz Tomaniak, Ply Chichareon, Rodrigo Modolo, Norihiro Kogame, Kuniaki Takahashi, Chun Chin Chang, Ernest Spitzer, Simon Walsh, David Adlam, David Hildick-Smith, István Édes, Pim Van der Harst, Florian Krackhardt, Jan Tijssen, Tessa Rademaker-Havinga, Scot Garg, Philippe Gabriel Steg, Christian Hamm, Peter JüniPascal Vranckx, Yoshinobu Onuma, Freek W.A. Verheugt

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

13 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: Insights from the randomised GLOBAL LEADERS trial'. Together they form a unique fingerprint.

Medicine & Life Sciences